Scientists Engineered Bacteria to Invade and Destroy Cancer Tumors From the Inside Out

Cancer research has produced some extraordinary breakthroughs over the past decade, but few approaches are as audacious as what a team at the University of Waterloo is now building. Researchers have engineered bacteria to invade solid tumors, colonize their oxygen-free cores, and consume cancer tissue from within. What sounds like science fiction is backed by two published studies, a functional synthetic biology system, and a clear path toward pre-clinical trials. For cancer, this development is exactly as bad as it sounds.

Why Tumors Are Actually the Perfect Bacterial Target

Solid tumors have a structural weakness that most cancer treatments cannot exploit. At the center of a tumor, cells are so densely packed and so far from the nearest blood vessel that oxygen cannot reach them. Without oxygen, those central cells die, leaving behind a necrotic, nutrient-rich core that most therapies struggle to penetrate. For certain bacteria, that core is not a problem. It is a paradise.

Clostridium sporogenes is a soil bacterium that can only survive in environments with absolutely no oxygen. It is an obligate anaerobe, meaning oxygen does not just slow it down; it kills it. A tumor’s dead, oxygen-free center gives this organism everything it needs: shelter from oxygen, abundant nutrients, and space to multiply without competition.

Marc Aucoin, a chemical engineering professor at the University of Waterloo who leads the research, described the process directly. Bacterial spores enter the tumor and find an environment with lots of nutrients and no oxygen, which the organism prefers, so it starts consuming those nutrients and growing. As he put it, the bacterium colonizes that central space and essentially rids the body of the tumor.

The Oxygen Problem at the Tumor’s Edge

Colonizing the tumor core is one thing. Destroying the entire tumor is another. As Clostridium sporogenes multiplies and expands outward from the necrotic center, it eventually reaches the outer regions of the tumor, where blood vessels still supply low but detectable levels of oxygen. At that point, the bacteria begin to die before finishing the job.

Left unaddressed, this limitation means the bacteria can hollow out a tumor’s core without clearing its edges, where living, dividing cancer cells still reside. Researchers needed a way to extend the bacteria’s reach into those oxygen-adjacent zones without creating a safety risk.

Their first solution was genetic. They identified a related bacterium with greater oxygen tolerance and extracted the relevant gene. By inserting that gene into Clostridium sporogenes, they gave the engineered strain the ability to survive in the low-oxygen conditions found near the tumor’s outer boundary. On paper, that solved the oxygen problem. In practice, it created a new one.

The Safety Problem That Quorum Sensing Solves

An oxygen-tolerant bacterium that can survive near the edges of a tumor can also, in theory, survive in other low-oxygen environments in the body, including the bloodstream. Activating the oxygen-tolerance gene too early, before the bacteria are safely established inside the tumor, could allow them to spread through healthy tissue. That risk made the timing of gene activation a critical engineering challenge.

The solution came from biology itself. Bacteria naturally communicate with each other through a process called quorum sensing. Individual bacterial cells continuously release small chemical signals called autoinducing peptides into their environment. When bacterial numbers are low, those signals stay dilute. As the population grows, the signals accumulate. Once they reach a threshold concentration, they trigger changes in gene expression across the entire population simultaneously.

In other words, quorum sensing is the bacterial equivalent of a vote. When enough members of the population signal that conditions are right, the group acts together. Researchers used this built-in communication system to control when the oxygen-tolerance gene switches on. Only after enough bacteria have multiplied inside the tumor, when quorum sensing signals reach the activation threshold, does the oxygen-resistant mechanism engage. At that point, the bacteria are already deep inside the tumor and far from healthy tissue.

Building a Biological Circuit From DNA

To implement quorum sensing control in Clostridium sporogenes, the team had to engineer a system that does not naturally exist in this bacterium. They borrowed the agr quorum sensing system from Staphylococcus aureus, a well-studied Gram-positive bacterium, and built it into Clostridium sporogenes using synthetic biology techniques.

Brian Ingalls, a professor of applied mathematics at Waterloo, described the process in terms that make the engineering logic clear. Using synthetic biology, the team built something like an electrical circuit, but instead of wires they used pieces of DNA. Each piece has a specific job, and when assembled correctly, they form a system that works in a predictable way.

To confirm the system worked, researchers programmed the engineered bacteria to produce green fluorescent protein whenever quorum sensing activated. If the bacteria lit up green at the right moment and in response to the right conditions, the circuit was functioning as designed. Results confirmed it was. Using mass spectrometry, researchers verified that the engineered bacteria produced the autoinducing peptides needed to trigger quorum sensing. The fluorescent reporter activated in response to increasing cell density, exactly as intended.

Researchers also confirmed that replacing the culture medium with fresh liquid delayed quorum sensing activation, because it washed away the accumulated signal molecules. When signal molecules could not build up, the population could not reach the communication threshold needed to trigger the genetic switch. Diluting the signal meant delaying the response, which validated that signal accumulation was the true driver of activation.

What Happens When the System Is Disrupted

One additional finding from the quorum sensing study has potential implications for treatment control. Researchers discovered that a different chemical signal from a related but non-matching quorum sensing group acted as a competitive antagonist. When this non-matching signal was present, it blocked activation of the gene under quorum sensing control, even when bacterial density was high enough to normally trigger it.

In a clinical context, this opens a possible off switch. If a patient’s treatment needed to be paused or stopped, introducing a competing signal could potentially suppress bacterial activity, giving physicians a mechanism for managing the therapy if complications arose. Engineered control over both activation and suppression makes the system more tractable as a medical treatment.

Where the Research Stands Now

Both studies represent sequential steps in a larger development program. In the first study, researchers demonstrated that Clostridium sporogenes could be genetically modified to tolerate oxygen. In the follow-up study, they successfully engineered and validated the quorum sensing control system using a fluorescent reporter.

What has not yet been done is combining both components into a single bacterium and testing that integrated system against an actual tumor. That step, bringing the oxygen-tolerance gene and the quorum sensing activation circuit together into one organism, is the next phase of the research. Pre-clinical trials using that combined strain are the goal researchers are now working toward.

The project grew from doctoral work by Bahram Zargar, supervised by Ingalls and retired chemical engineering professor Pu Chen. Zargar subsequently co-founded CREM Co Labs, a Toronto-based microbiology research company, which is now partnering with the Waterloo team on continued development. Former Waterloo doctoral student Sara Sadr has also played a leading role in advancing the research.

Why This Approach Could Succeed Where Others Fall Short

Many cancer treatments fail at the same place these bacteria are designed to succeed: the tumor’s interior. Chemotherapy drugs and immune cells both depend on blood flow to reach cancer tissue. The necrotic core of a solid tumor, cut off from circulation, becomes a sanctuary where cancer cells survive treatment and disease eventually recurs. Radiation can penetrate that core, but it also damages surrounding healthy tissue in the process.

Bacteria that prefer exactly that environment represent a fundamentally different strategy. Rather than fighting the tumor’s biology, this approach works with it. The oxygen-free core that protects cancer from other treatments becomes the entry point and breeding ground for the therapeutic agent. Rather than struggling to deliver medicine to a poorly vascularized environment, researchers are sending organisms that do not need vascular access at all and that thrive where the conditions are worst.

For cancers defined by large, solid tumors with hypoxic cores, including certain pancreatic, colorectal, and lung cancers, this targeting specificity could matter considerably.

The Bigger Picture for Cancer Treatment

Bacterial cancer therapy is not entirely new. Researchers have explored using bacteria to target tumors for over a century, with early interest dating back to observations that some cancer patients improved after bacterial infections. What is new here is the precision engineering that allows researchers to control bacterial behavior at the genetic level, turning specific functions on and off based on environmental signals inside the tumor itself.

Quorum sensing-based control, oxygen tolerance gene regulation, and the use of synthetic DNA circuits to program predictable bacterial behavior all represent tools that were not available in earlier eras of this research. Bringing them together in an obligate anaerobe that naturally seeks out the tumor core creates a level of specificity and programmability that previous attempts at bacterial cancer therapy lacked.

Researchers are also studying whether blood factors from other sources can help activate or regulate these systems, and whether combining bacterial therapy with existing treatments like immunotherapy could amplify results. Each of these directions depends on the foundational genetic engineering work that the Waterloo team has now published and validated.

My Personal RX on Supporting Your Body Against Cancer With Daily Habits

As a doctor, I find research like this genuinely exciting, because it reflects a growing understanding that cancer has biological vulnerabilities we can target with increasing precision. But while science moves toward treatments like this, the best tools available to most people right now are the ones sitting in their daily routines. Cancer does not appear overnight. It develops over years, in tissue made more vulnerable by chronic inflammation, oxidative stress, poor gut health, and an immune system that is not functioning at its best. Every healthy choice you make is a form of prevention, and prevention compounds over time just as disease risk does. You do not need to wait for the next breakthrough to start protecting yourself. Start with what you can control today.

1. Reduce Chronic Inflammation Through Diet: Chronic inflammation creates the cellular environment where cancer risk rises. Prioritize anti-inflammatory foods including fatty fish, leafy greens, berries, olive oil, and turmeric. Limit processed foods, refined sugars, and seed oils that promote inflammatory signaling.
   
2. Exercise Regularly to Lower Cancer Risk: Physical activity reduces circulating levels of insulin, estrogen, and inflammatory markers that raise cancer risk. Aim for at least 150 minutes of moderate aerobic exercise per week, combined with two sessions of resistance training.
   
3. Prioritize Deep, Restorative Sleep: Your immune system conducts its most active cancer surveillance during deep sleep. Disrupted or insufficient sleep raises inflammatory cytokines and weakens natural killer cell activity, two factors that increase cancer vulnerability. Sleep Max supports restorative REM sleep with magnesium, GABA, 5-HTP, and taurine to help your body run its nightly immune maintenance cycle.
   
4. Know Your Nutritional Gaps: Vitamin D, selenium, zinc, and omega-3 fatty acids all support immune function and cellular repair. Many adults run chronically low on these nutrients without knowing it. Download The 7 Supplements You Can’t Live Without, a free guide that covers the key nutrients that affect immunity, cellular health, and energy after 40, along with how to identify supplements that actually deliver results.
   
5. Avoid Tobacco in Every Form: Tobacco smoke contains dozens of carcinogens that damage DNA in ways that drive tumor formation across multiple organ systems. No level of tobacco exposure is safe, and quitting at any age reduces risk.
   
6. Limit Alcohol: Alcohol is a Group 1 carcinogen. Regular consumption raises the risk of breast, colon, liver, and esophageal cancers. Limiting intake to occasional and moderate levels, or eliminating it, reduces that risk substantially.
   
7. Maintain a Healthy Body Weight: Excess adipose tissue, especially visceral fat, produces estrogen and inflammatory cytokines that drive cancer cell growth. Weight management through diet and exercise reduces cancer risk across more than a dozen cancer types.
   
8. Stay Current With Screenings: Early detection saves lives. Colonoscopy, mammography, PSA testing, cervical screening, and lung CT scans for high-risk individuals all catch cancer at stages when treatment is most effective. Know your risk factors and talk to your doctor about the right screening schedule for you.

Source: Sadr, S., Zargar, B., Aucoin, M. G., & Ingalls, B. (2025). Construction and Functional Characterization of a Heterologous Quorum Sensing Circuit in Clostridium sporogenes. ACS Synthetic Biology, 14(12), 4857–4868. https://doi.org/10.1021/acssynbio.5c00628